These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 23690925)
21. Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Feng J; Ma Y; Chen Z; Hu J; Yang Q; Ding G Life Sci; 2019 Nov; 237():116941. PubMed ID: 31606382 [TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of novel MPC1 gene variants causing mitochondrial pyruvate carrier deficiency. Jiang H; Alahmad A; Fu S; Fu X; Liu Z; Han X; Li L; Song T; Xu M; Liu S; Wang J; Albash B; Alaqeel A; Catalina V; Prokisch H; Taylor RW; McFarland R; Fang F J Inherit Metab Dis; 2022 Mar; 45(2):264-277. PubMed ID: 34873722 [TBL] [Abstract][Full Text] [Related]
23. The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism. Yiew NKH; Finck BN Am J Physiol Endocrinol Metab; 2022 Jul; 323(1):E33-E52. PubMed ID: 35635330 [TBL] [Abstract][Full Text] [Related]
25. Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction. Oonthonpan L; Rauckhorst AJ; Gray LR; Boutron AC; Taylor EB JCI Insight; 2019 May; 5(13):. PubMed ID: 31145700 [TBL] [Abstract][Full Text] [Related]
26. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615 [TBL] [Abstract][Full Text] [Related]
27. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes. Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179 [TBL] [Abstract][Full Text] [Related]
28. Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets. Rohatgi N; Aly H; Marshall CA; McDonald WG; Kletzien RF; Colca JR; McDaniel ML PLoS One; 2013; 8(5):e62012. PubMed ID: 23650507 [TBL] [Abstract][Full Text] [Related]
29. MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer. Li X; Ji Y; Han G; Li X; Fan Z; Li Y; Zhong Y; Cao J; Zhao J; Zhang M; Wen J; Goscinski MA; Nesland JM; Suo Z BMC Cancer; 2016 Nov; 16(1):894. PubMed ID: 27852261 [TBL] [Abstract][Full Text] [Related]
30. Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-α and leptin, and adipose tissue gene expression. Schoenberg KM; Perfield KL; Farney JK; Bradford BJ; Boisclair YR; Overton TR J Dairy Sci; 2011 Nov; 94(11):5523-32. PubMed ID: 22032375 [TBL] [Abstract][Full Text] [Related]
31. Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses. Li X; Li Y; Han G; Li X; Ji Y; Fan Z; Zhong Y; Cao J; Zhao J; Mariusz G; Zhang M; Wen J; Nesland JM; Suo Z Oncotarget; 2016 Nov; 7(48):79981-79994. PubMed ID: 27835892 [TBL] [Abstract][Full Text] [Related]
33. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells. Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033 [TBL] [Abstract][Full Text] [Related]
35. Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity. Wellen KE; Uysal KT; Wiesbrock S; Yang Q; Chen H; Hotamisligil GS Endocrinology; 2004 May; 145(5):2214-20. PubMed ID: 14764635 [TBL] [Abstract][Full Text] [Related]
36. Insulin sensitizers in 2023: lessons learned and new avenues for investigation. Colca JR; Tanis SP; Kletzien RF; Finck BN Expert Opin Investig Drugs; 2023; 32(9):803-811. PubMed ID: 37755339 [TBL] [Abstract][Full Text] [Related]
37. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle. Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476 [TBL] [Abstract][Full Text] [Related]
38. Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases. Colca JR; Tanis SP; McDonald WG; Kletzien RF Expert Opin Investig Drugs; 2014 Jan; 23(1):1-7. PubMed ID: 24073940 [TBL] [Abstract][Full Text] [Related]
39. Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION. Vadvalkar SS; Matsuzaki S; Eyster CA; Giorgione JR; Bockus LB; Kinter CS; Kinter M; Humphries KM J Biol Chem; 2017 Mar; 292(11):4423-4433. PubMed ID: 28154187 [TBL] [Abstract][Full Text] [Related]
40. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Digby JE; Montague CT; Sewter CP; Sanders L; Wilkison WO; O'Rahilly S; Prins JB Diabetes; 1998 Jan; 47(1):138-41. PubMed ID: 9421389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]